Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a listing in its bid to shed the business. The French drugmaker laid out plans to separate its consumer division—home to brands such as Allegra, Dulcolax and IcyHot—from its innovative medicines and vaccines businesses a year ago. With its decision, Sanofi joined peers Johnson & Johnson, Pfizer and GSK in hiving off businesses that sell over-the-counter medicines to focus on more lucrative, but riskier, prescription drugs. Sanofi’s negotiations with CD&R show the Paris-based company is following a different path to exit the business, though.
Read the full article: Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CD&R //
Source: https://www.wsj.com/business/deals/sanofi-enters-talks-to-sell-controlling-stake-in-consumer-health-unit-to-cd-r-0985611c